Celéri Health Announces Enrollment of First Patient in Study of Real World Outcomes® for Medtronic DTM™ Spinal Cord Stimulation (SCS)

February 2021 – 

PRESS RELEASE – February 22, 2021, Conshohocken, PA – Celéri Health, a leader in using Real World Outcomes® to change the paradigm of care for people living with chronic pain, today announced the first patient has been enrolled in the UPGRADE Study, which is a large registry of patients using DTM™ Spinal Cord Stimulation (SCS) available only on the Medtronic Intellis™ platform. The first patient was enrolled on January 29, 2021 at Jax Spine & Pain Centers in Jacksonville, Florida by Dr. Michael Hanes.  The UPGRADE registry will capture long-term, real-world outcomes to understand the effect of DTM SCS programming in the SCS implanted population on the management of chronic pain, primarily on its use for trunk and/or limb pain. The clinical study is sponsored by Celéri Health and is supported by Medtronic’s External Research Program. The registry study will be conducted across approximately 20-30 centers in the United States with up to 1700 patients enrolled. here: https://www.globenewswire.com/news-release/2021/02/23/2180427/0/en/Cel%C3%A9ri-Health-Announces-Enrollment-of-First-Patient-in-Study-of-Real-World-Outcomes-for-Medtronic-DTM-Spinal-Cord-Stimulation-SCS.html